Dissolvable Alginate Microwells for Vascularized Microtissue Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing spheroid microtissues lack simplicity and control over size distribution, are difficult to scale, and face challenges in vascularization and injectability, which are critical for regenerative medicine and treating ischemic conditions such as critical limb ischemia.
Innovation Solution
A method using dissolvable alginate microwells to culture endothelial cells and mesenchymal stem cells, allowing them to self-organize into spheroids with a primitive vasculature, which can be harvested and injected to form a functional vascular network in vivo, leveraging timed exposure to growth factors for directed self-organization and maturation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional spheroid production methods (hanging-drop, centrifugation, spinner cultures) are used, then spheroids can be formed, but size distribution control is poor and production scalability is limited
Solution Approach 1:
The invention segments the production process by using individual microwells for each spheroid, allowing independent size control through well diameter selection. This enables parallel production of many spheroids with uniform sizes, resolving the contradiction between precision and scalability.
Solution Approach 2:
The invention changes the physical parameter of the culture environment by using microwells with specific diameter ranges (50-500 μm) to control spheroid size. By selecting appropriate well diameters, spheroids of desired sizes can be produced with high precision while maintaining scalability through array-based parallel cultivation.
2Volume of moving object
If spheroids are made large enough to be useful for tissue engineering, then they can provide functional tissue, but vascularization becomes limited due to diffusion constraints
Solution Approach 1:
The invention segments large tissue volume into multiple small spheroids (200-500 μm diameter) that can be injected together. Each spheroid remains within the diffusion limit for reliable vascularization, while collectively they provide the desired large tissue volume through in vivo aggregation.
Solution Approach 2:
The invention transitions from trying to vascularize a single large spheroid to using multiple small spheroids distributed in three-dimensional space. This dimensional approach allows each unit to be adequately vascularized while achieving overall large tissue volume through spatial arrangement.
3Reliability
If pre-vascularized scaffolds are used to promote vascularization, then blood vessel formation can be enhanced, but scaffold incompatibility and complexity increase
Solution Approach 1:
The invention extracts the vascularization function from complex scaffolds and concentrates it into endothelial cell cores within simple spheroid structures. This removes the need for complicated scaffold designs while maintaining effective vascularization capability.
Solution Approach 2:
The invention applies vascularization capability locally at the center of each spheroid through endothelial cell cores, rather than requiring uniform vascularization throughout a complex scaffold structure. This localized approach simplifies the overall system while maintaining effectiveness.
4Reliability
If host blood vessel invasion is used for vascularization, then vascular integration can occur, but the process is slow and limited to several tenths of micrometers per day
Solution Approach 1:
The invention performs preliminary vascularization by pre-forming endothelial cell cores within spheroids before injection. This preliminary action provides immediate vascular structures that can rapidly integrate with host vessels, eliminating the slow initial phase of host vessel invasion.
Solution Approach 2:
The spheroids self-organize endothelial cell cores internally without requiring host vessel invasion to initiate vascularization. This self-service mechanism provides intrinsic vascularization capability that accelerates the overall integration process.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the high-throughput production of spheroids with controlled size and vascular architecture, facilitating rapid vascularization and integration with host vasculature, potentially treating ischemic conditions without invasive surgery.
Implementation Method 1
Spheroids form when multiple individual cells aggregate and then adhere to each other more strongly than surrounding materials
Implementation Method 2
A method using dissolvable alginate micrawells to culture endothelial cells and mesenchymal stem cells
Data Source
AI summary
Spheroid microtissues that can mimic native tissue-like structure and function, spheroid production methods that are high-throughput, suitable for efficient production, maintainable over long-term culture, and/or offer repeatable control over size distribution. Spheroids that have blood vessels, including spheroids with functional, blood-perfused vascular networks upon injection in vivo. Dissolvable hydrogel microwell arrays for high throughput parallel formation of spheroids in a single pipetting step and easy retrieval for downstream applications. A method to produce prevascularized microtissues in sufficient numbers to form a macrotissue in vivo for therapeutic purposes. This method is based on sacrificial release of dissolvable microwell templates, a novel and scalable strategy which enables gentle harvesting of microtissues with control over size and composition. The method forms microtissues containing endothelial cells and mesenchymal stem cells, which are co-cultured under dynamic conditions and self-organize into blood-vessel units.